BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1409 related articles for article (PubMed ID: 32172226)

  • 1. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
    Han H; Yang L; Liu R; Liu F; Wu KL; Li J; Liu XH; Zhu CL
    Clin Chem Lab Med; 2020 Jun; 58(7):1116-1120. PubMed ID: 32172226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathy in COVID-19: Manifestations and management.
    Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
    Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
    Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
    J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.
    Tang N; Li D; Wang X; Sun Z
    J Thromb Haemost; 2020 Apr; 18(4):844-847. PubMed ID: 32073213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.
    Cui S; Chen S; Li X; Liu S; Wang F
    J Thromb Haemost; 2020 Jun; 18(6):1421-1424. PubMed ID: 32271988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.
    Wright FL; Vogler TO; Moore EE; Moore HB; Wohlauer MV; Urban S; Nydam TL; Moore PK; McIntyre RC
    J Am Coll Surg; 2020 Aug; 231(2):193-203.e1. PubMed ID: 32422349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.
    Bi X; Su Z; Yan H; Du J; Wang J; Chen L; Peng M; Chen S; Shen B; Li J
    Platelets; 2020 Jul; 31(5):674-679. PubMed ID: 32367765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis.
    Long H; Nie L; Xiang X; Li H; Zhang X; Fu X; Ren H; Liu W; Wang Q; Wu Q
    Biomed Res Int; 2020; 2020():6159720. PubMed ID: 32596339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19.
    Liu Y; Gao W; Guo W; Guo Y; Shi M; Dong G; Ge Q; Zhu J; Lu J
    J Thromb Thrombolysis; 2020 Nov; 50(4):825-832. PubMed ID: 32761495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
    Spiezia L; Boscolo A; Poletto F; Cerruti L; Tiberio I; Campello E; Navalesi P; Simioni P
    Thromb Haemost; 2020 Jun; 120(6):998-1000. PubMed ID: 32316063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis.
    Zhang Y; He L; Chen H; Lu S; Xiong Y; Liu J; Zheng Y; Wang S; Liu L
    Int J Lab Hematol; 2020 Dec; 42(6):766-772. PubMed ID: 32592539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China.
    Zou Y; Guo H; Zhang Y; Zhang Z; Liu Y; Wang J; Lu H; Qian Z
    Biosci Trends; 2020 Sep; 14(4):285-289. PubMed ID: 32350161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation abnormalities and thrombosis in patients with COVID-19.
    Levi M; Thachil J; Iba T; Levy JH
    Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
    [No Abstract]   [Full Text] [Related]  

  • 15. Coagulation Panel in Patients with SARS-CoV2 Infection (COVID-19).
    Guevara-Noriega KA; Lucar-Lopez GA; Nuñez G; Rivera-Aguasvivas L; Chauhan I
    Ann Clin Lab Sci; 2020 May; 50(3):295-298. PubMed ID: 32581015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Coagulopathy and Inflammation: The Knowns and Unknowns.
    Wanderer JP; Nathan N
    Anesth Analg; 2020 Nov; 131(5):1323. PubMed ID: 33079849
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemostatic abnormalities in COVID-19: A guided review.
    Sathler PC
    An Acad Bras Cienc; 2020; 92(4):e20200834. PubMed ID: 32844987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The values of coagulation function in COVID-19 patients.
    Jin X; Duan Y; Bao T; Gu J; Chen Y; Li Y; Mao S; Chen Y; Xie W
    PLoS One; 2020; 15(10):e0241329. PubMed ID: 33119703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine haematology parameters in COVID-19 patients and clinical outcome: A Belgian single-centre study.
    Demeester S; Demuyser T; Fauconnier C; Heestermans R; Orlando C; Depreter B; Jochmans K
    Int J Lab Hematol; 2020 Dec; 42(6):e252-e255. PubMed ID: 32915507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 71.